IVVD compared with PALI: revenue, margins and what each company keeps, and the suppliers and customers both name

IVVDInvivyd, Inc.

Mkt capRevenueRevenue

PALIPalisade Bio, Inc.

Mkt capRevenueRevenue

Compare

IVVDInvivyd, Inc.

PALIPalisade Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IVVD 9

—Undisclosed specialty distributor customerunlistedcustomer

—Adimabunlistedsupplier

—WuXi Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

5 more · IVVD chain ›

Shared 0

No shared counterparties.

Only PALI 2

—Giiant Pharmaunlistedsupplier

—Newsoaraunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

IVVDInvivyd, Inc.

0.59▼−2.76%· post 0.59

Mkt cap$171.5MRevenue$14MQ2 FY26Revenue$53MFY25

PALIPalisade Bio, Inc.

1.17▼−1.97%· post 1.16

ClosedOct 30 '26

Mkt cap$202.2MRevenue$500,000Q2 FY26Revenue—

Compare

ClosedOct 30 '26

IVVDInvivyd, Inc.

PALIPalisade Bio, Inc.

0.59▼−2.76%post 0.59

Price

1.17▼−1.97%post 1.16

$171.5M

Mkt cap

$202.2M

Q2 FY26$14M

Revenue

$500,000Q2 FY26

FY25$53M

Revenue

—

IVVD0.59▼−2.76%vsPALI1.17▼−1.97%ClosedOct 30 '26